Rationale employment of cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriers

被引:28
作者
Elsheikh, Manal A. [1 ,2 ]
Elnaggar, Yosra S. R. [1 ]
Abdallah, Ossama Y. [1 ]
机构
[1] Univ Alexandria, Fac Pharm, Dept Pharmaceut, Alexandria, Egypt
[2] Damanhour Univ, Fac Pharm, Dept Pharmaceut, Damanhour, Egypt
关键词
Cell line; Nanomedicine; Permeability; Cytotoxicity; Targeting; BLOOD-BRAIN-BARRIER; DRUG-DELIVERY SYSTEMS; EX-VIVO PERMEATION; IN-VITRO MODELS; ORAL DELIVERY; INTESTINAL-ABSORPTION; HEPATOCELLULAR-CARCINOMA; PERMEABILITY ENHANCEMENT; LIPID NANOCARRIERS; SUSTAINED-RELEASE;
D O I
10.1016/j.jconrel.2014.08.019
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nanomedicines are enjoying a widespread popularity realizing their intriguing potential to solve drug delivery obstacles. Assessment of major quality attributes of nanocarriers is a crucial process for approving their therapeutic outcomes. Disparate assessment methods that recently encompassed cell line technique were employed. Routinely, a cell line model was viewed as an excellent platform for gene and vaccine deliveries. However, its application in pharmaceutical assessment of nanocarriers was not so far overviewed. This review provides a meticulous look at cell culture implementations in evaluation of major quality attributes of nanocarriers, including oral permeability, cytotoxicity and efficiency of tumor targeting. Among others, cell culture technique strikes the right balance between predictability and throughput. It could circumvent drawbacks of in-vivo and in-vitro techniques while gathering privileges of both. Imperative pharmaceutical considerations demanded for proper application of this technique were emphasized. Furthermore, challenges encountered in assessment of versatile nanocarriers were highlighted with proposed solutions. Finally, future research perspectives in this theme issue were suggested. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:92 / 102
页数:11
相关论文
共 100 条
[1]   Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I [J].
Abdel-Mottaleb, Mona M. A. ;
Lamprecht, Alf .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2011, 37 (02) :178-184
[2]  
Agrawal U S., 2014, Drug Discov Today, P1
[3]   Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug [J].
Alam, M. Intakhab ;
Baboota, Sanjula ;
Ahuja, Alka ;
Ali, Mushir ;
Ali, Javed ;
Sahni, Jasjeet K. ;
Bhatnagar, Aseem .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 470 (1-2) :99-106
[4]   Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies [J].
Araujo, Francisca ;
Sarmento, Bruno .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 458 (01) :128-134
[5]  
Artursson P., 2011, INT J PHARMACEUT, V403, P37
[6]   Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments [J].
Astashkina, Anna ;
Grainger, David W. .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 69 :1-18
[7]  
Babu H., 2005, FRONT NEUROSCI, V5, P1
[8]   Cell culture-based models for intestinal permeability: a critique [J].
Balimane, PV ;
Chong, S .
DRUG DISCOVERY TODAY, 2005, 10 (05) :335-343
[9]   Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake [J].
Barbieri, Stefano ;
Sonvico, Fabio ;
Como, Caterina ;
Colombo, Gaia ;
Zani, Franca ;
Buttini, Francesca ;
Bettini, Ruggero ;
Rossi, Alessandra ;
Colombo, Paolo .
JOURNAL OF CONTROLLED RELEASE, 2013, 167 (03) :276-283
[10]   Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier [J].
Beloqui, Ana ;
Angeles Solinis, Maria ;
Gascon, Alicia R. ;
del Pozo-Rodriguez, Ana ;
des Rieux, Anne ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2013, 166 (02) :115-123